UCL in the media
Employers reward workers that prioritise work ahead of life balance
“When workers want flexibility, freedom and wellness, those happy to ‘grind’ stand out even more than before,” said Professor Tomas Chamorro-Premuzic (UCL Clinical, Educational & Health Psychology).
,
Changing everyday behaviours could help delay dementia
“It would be great if we had drugs that worked, but they’re not the only way forward,” said Professor Gill Livingston (UCL Psychiatry).
,
Websites are safer for privacy than apps
Dr Michael Veale (UCL Laws) said it’s usually safer and better for privacy to access services through mobile browsers rather than apps which can collect a lot of data from your phone.
When should Parliament get involved with the royal family?
“It’s difficult to know where to draw the line. How far is it Parliament’s business how Prince Andrew has apparently been behaving?” said Dr Bob Morris (UCL Constitution Unit).
New fast battery technology proposed
“While [batteries] can store a lot of energy in a compact space, there’s a challenge in getting the energy in and out quickly,” said Professor Chris Howard (UCL Physics & Astronomy).
Different menopause treatment may needed for different people
“Many women don't want to take [hormone replacement therapy] (HRT) and we shouldn't be guilted into it,” said Professor Joyce Harper (UCL EGA Institute for Women’s Health).
New Covid-19 drug could help people who couldn’t take the vaccine
“I’ve got friends who are immunocompromised who are still locked in the house and terrified to go out. This drug could set them free,” said Professor Hugh Montgomery (UCL Experimental & Translational Medicine).
Recreating lost smells of the past
“There has been a hierarchy of the senses in science and in historical study. We want to see a multisensory approach,” said Cecilia Bembibre Jacobo (UCL Bartlett School Environment, Energy & Resources).
Developing a vaccine ahead of the next Covid wave
“If you wait until the last moment, you will have the best chance of designing a vaccine that is best able to tackle the variant that is most widespread but you do not want to risk production failing to deliver sufficient doses,” said Professor Francois Balloux (UCL Biosciences).
,
Correlation between AstraZeneca vaccine and autoimmune disorder
“Higher numbers of cases of [Guillan-Barre Syndrome] are seen in the period of two to four weeks after vaccination. A peak of cases observed around 24 days following a first dose,” said Professor Michael Lunn (UCL Queen Square Institute of Neurology).